Results 11 to 20 of about 5,139,728 (295)
Accuracy of High Resolution Multidetector Computed Tomography in the Local Staging of Rectal Cancer
Journal of Gastrointestinal and Abdominal Radiology, 2022 Background Magnetic resonance imaging (MRI) is the gold standard for local staging of rectal cancer. Advanced computed tomography (CT) machines are now capable of high-resolution images of rectal cancer and utilized for CT perfusion.Rochita Venkata Ramanan, Venkatesh Munikrishnan, Akash Venkataramanan, Sudeepta Kumar Swain, Kaveripattu Sathiyamurthy Sunilkumar, Vadanika Venu, Muthuswamy Hariharan, Mohammad Zehran Saipillai, Asfar Ahamed +8 moredoaj +1 more sourceShort-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
The Lancet Oncology, 2020 BACKGROUND
Systemic relapses remain a major problem in locally advanced rectal cancer. Using short-course radiotherapy followed by chemotherapy and delayed surgery, the Rectal cancer And Preoperative Induction therapy followed by Dedicated Operation ...R. Bahadoer, E. Dijkstra, B. van Etten, C. Marijnen, H. Putter, E. Kranenbarg, A. Roodvoets, I. Nagtegaal, R. Beets-Tan, L. Blomqvist, T. Fokstuen, A. T. Ten Tije, J. Capdevila, M. Hendriks, I. Edhemovic, A. Cervantes, P. Nilsson, B. Glimelius, C. J. van de Velde, G. Hospers +19 moresemanticscholar +1 more sourceMRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response.
Clinical colorectal cancer, 2021 Rectal cancer is a relatively common malignancy in the United States. Magnetic resonance imaging (MRI) of rectal cancer has evolved tremendously in recent years, and has become a key component of baseline staging and treatment planning.D. Bates, M. Homsi, Kevin Chang, N. Lalwani, N. Horvat, S. Sheedy +5 moresemanticscholar +1 more sourceComprehensive molecular characterization of human colon and rectal cancer
Nature, 2012 To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale analysis of 276 samples, analysing exome sequence, DNA copy number, promoter methylation and messenger RNA and microRNA expression.D. Muzny, M. Bainbridge, K. Chang, H. Dinh, J. Drummond, G. Fowler, C. Kovar, L. Lewis, M. Morgan, I. Newsham, J. Reid, J. Santibanez, E. Shinbrot, L. Treviño, Yuan-qing Wu, Min Wang, P. Gunaratne, L. Donehower, C. Creighton, D. Wheeler, R. Gibbs, M. Lawrence, D. Voet, R. Jing, K. Cibulskis, A. Sivachenko, P. Stojanov, A. McKenna, E. Lander, S. Gabriel, L. Ding, R. Fulton, D. Koboldt, T. Wylie, Jason R. Walker, D. Dooling, L. Fulton, K. Delehaunty, C. Fronick, Ryan T. Demeter, E. Mardis, R. Wilson, Andy Chu, Hye-Jung E. Chun, A. Mungall, E. Pleasance, A. G. Robertson, D. Stoll, M. Balasundaram, I. Birol, Y. Butterfield, E. Chuah, R. Coope, Noreen Dhalla, R. Guin, Carrie Hirst, M. Hirst, R. Holt, Darlene Lee, H. Li, Michael Mayo, Richard A. Moore, J. Schein, Jared R. Slobodan, Angela Tam, N. Thiessen, R. Varhol, Thomas Zeng, Yongjun Zhao, Steven J. M. Jones, M. Marra, A. Bass, A. Ramos, G. Saksena, A. Cherniack, S. Schumacher, B. Tabak, S. Carter, Nam Pho, Huy L. Nguyen, R. Onofrio, A. Crenshaw, K. Ardlie, R. Beroukhim, W. Winckler, M. Meyerson, A. Protopopov, Angela Hadjipanayis, E. Lee, Ruibin Xi, Lixing Yang, X. Ren, N. Sathiamoorthy, Peng-Chieh Chen, Psalm S. Haseley, Yonghong Xiao, Semin Lee, J. Seidman, L. Chin, P. Park, R. Kucherlapati, J. Auman, K. Hoadley, Ying Du, M. Wilkerson, Yan Shi, C. Liquori, S. Meng, Ling Li, Yidi J. Turman, M. D. Topal, Donghui Tan, S. Waring, Elizabeth Buda, Jesse L. Walsh, Corbin D. Jones, P. Mieczkowski, Darshan Singh, Junyuan Wu, Anisha Gulabani, Peter Dolina, T. Bodenheimer, A. Hoyle, J. Simons, Matthew G. Soloway, Lisle E. Mose, S. Jefferys, S. Balu, Brian D. O’Connor, J. Prins, Derek Y. Chiang, D. Hayes, C. Perou, T. Hinoue, D. Weisenberger, D. Maglinte, F. Pan, B. Berman, D. V. Berg, Hui Shen, T. Triche, S. Baylin, P. Laird, G. Getz, M. Noble, Doug Voat, Nils Gehlenborg, D. Dicara, Juinhua Zhang, Hailei Zhang, Chang-Jiun Wu, Spring Yingchun Liu, S. Shukla, Lihua Zhou, Pei Lin, R. Park, Marc-Danie Nazaire, James Robinson, H. Thorvaldsdóttir, J. Mesirov, V. Thorsson, Sheila M. Reynolds, Brady Bernard, R. Kreisberg, Jake Lin, L. Iype, Ryan Bressler, Timo Erkkilä, M. Gundapuneni, Yuexin Liu, Adam Norberg, Thomas Robinson, Da Yang, Wei Zhang, I. Shmulevich, J. J. Ronde, N. Schultz, E. Cerami, G. Ciriello, A. Goldberg, Benjamin E. Gross, A. Jacobsen, Jianjiong Gao, B. Kaczkowski, Rileen Sinha, B. A. Aksoy, Yevgeniy Antipin, B. Reva, R. Shen, B. Taylor, M. Ladanyi, C. Sander, Rehan Akbani, Nianxiang Zhang, B. Broom, Tod D. Casasent, A. Unruh, Chris Wakefield, S. Hamilton, R. Cason, K. Baggerly, J. Weinstein, D. Haussler, C. Benz, Joshua M. Stuart, S. Benz, J. Z. Sanborn, Charles J. Vaske, Jingchun Zhu, C. Szeto, G. Scott, C. Yau, S. Ng, Theodore Goldstein, K. Ellrott, E. Collisson, A. E. Cozen, D. Zerbino, C. Wilks, Brian Craft, P. Spellman, R. Penny, T. Shelton, M. Hatfield, S. Morris, P. Yena, C. Shelton, M. Sherman, J. Paulauskis, J. Gastier-Foster, Jay Bowen, N. Ramirez, Aaron D. Black, R. Pyatt, L. Wise, P. White, M. Bertagnolli, Jennifer Brown, T. Chan, Gerald C. Chu, Christine Czerwinski, F. Denstman, R. Dhir, A. Dörner, C. Fuchs, J. Guillem, M. Iacocca, H. Juhl, Andrew Kaufman, B. Kohl, X. Le, M. C. Mariano, Elizabeth N. Medina, M. Meyers, G. Nash, P. Paty, N. Petrelli, B. Rabeno, W. Richards, D. Solit, P. Swanson, L. Temple, J. Tepper, Richard A. Thorp, E. Vakiani, M. Weiser, J. Willis, G. Witkin, Z. Zeng, M. Zinner, C. Zornig, M. Jensen, R. Sfeir, A. Kahn, A. Chu, Prachi Kothiyal, Zhining Wang, E. Snyder, J. Pontius, T. Pihl, B. Ayala, M. Backus, Jessica L Walton, J. Whitmore, J. Baboud, D. Berton, M. Nicholls, D. Srinivasan, R. Raman, Stanley Girshik, Peter A. Kigonya, S. Alonso, Rashmi N. Sanbhadti, S. Barletta, J. Greene, D. Pot, K. Shaw, Laura A. L. Dillon, K. Buetow, Tanja Davidsen, J. Demchok, G. Eley, M. Ferguson, P. Fielding, C. Schaefer, Margi Sheth, Liming Yang, M. Guyer, B. Ozenberger, Jacqueline D. Palchik, Jane L. Peterson, H. Sofia, E. Thomson +312 moresemanticscholar +1 more sourceNCCN Guidelines Insights: Rectal Cancer, Version 6.2020.
The Journal of the National Comprehensive Cancer Network, 2020 The NCCN Guidelines for Rectal Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with rectal cancer. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the ...A. Benson, A. Venook, M. Al-Hawary, M. Arain, Yi-Jen Chen, K. Ciombor, S. Cohen, H. Cooper, D. Deming, I. Garrido-Laguna, J. Grem, A. Gunn, S. Hoffe, J. Hubbard, S. Hunt, Natalie N. Kirilcuk, S. Krishnamurthi, W. Messersmith, J. Meyerhardt, E. Miller, M. Mulcahy, Steven J. Nurkin, M. Overman, A. Parikh, Hitendra R. H. Patel, K. Pedersen, L. Saltz, C. Schneider, D. Shibata, J. Skibber, C. Sofocleous, E. Stoffel, E. Stotsky-Himelfarb, C. Willett, Alyse Johnson-Chilla, Lisa A. Gurski +35 moresemanticscholar +1 more sourceRectal metastasis of gastric cancer: a case report
Journal of International Medical Research, 2023 The most common metastatic sites of gastric cancer include the liver, peritoneum, lung, and bone. However, there is a lack of relevant clinical reports regarding rectal metastasis.Lu Tang, Huifen Li, Jing Lv, Cantu Fang, Huatang Zhang, Jincheng Meng +5 moredoaj +1 more sourceEstudio de la frecuencia, distribución y rendimiento diagnóstico en las lesiones neoplásicas sincrónicas del carcinoma colo-rectal [PDF]
, 2008 To analyse the frequency, characteristics and
diagnosis of synchronic neoplastic lesions in colorectal cancer.
A review was carried out of 384 colorectal
cancers, diagnosed through complete colonoscopy and
resected.Borda-Celaya, F. (F.), Borda-Martin, A. (Ana), Carretero, C. (Cristina), Martinez-Peñuela, J.M. (J.M.), Muñoz-Navas, M. (Miguel), Prieto-Martinez, C. (C.) +5 morecore +1 more sourceCáncer Colo-rectal
Oncología, 2022
El Cáncer colo-rectal (CCR) representa, en nuestro medio, el segundo tumor digestivo en frecuencia. La secuencia adenoma-carcinoma en CCR ha sido bien establecida.Germán Reyes, Iván Nieto, Ernesto Paladines, Francisco Mendoza, Juan Tanca, Carlos Marengo +5 moredoaj Estudio de las lesiones neoplásicas metacrónicas en el carcinoma colorrectal [PDF]
, 2009 Fundamento.
Analizar la frecuencia y las características de las lesiones neoplásicas metacrónicas, carcinomas y adenomas, tras la resección de un cáncer colo-rectal (CCR).
Pacientes y métodos.Borda-Celaya, F. (F.), Borda-Martin, A. (Ana), Carretero, C. (Cristina), Jimenez, F.J. (F. J.), Martinez-Peñuela, J.M. (J.M.), Muñoz-Navas, M. (Miguel) +5 morecore +1 more source
